444 related articles for article (PubMed ID: 15980055)
1. Cross-talk between farnesoid-X-receptor (FXR) and peroxisome proliferator-activated receptor gamma contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis.
Fiorucci S; Rizzo G; Antonelli E; Renga B; Mencarelli A; Riccardi L; Morelli A; Pruzanski M; Pellicciari R
J Pharmacol Exp Ther; 2005 Oct; 315(1):58-68. PubMed ID: 15980055
[TBL] [Abstract][Full Text] [Related]
2. The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis.
Fiorucci S; Antonelli E; Rizzo G; Renga B; Mencarelli A; Riccardi L; Orlandi S; Pellicciari R; Morelli A
Gastroenterology; 2004 Nov; 127(5):1497-512. PubMed ID: 15521018
[TBL] [Abstract][Full Text] [Related]
3. A farnesoid x receptor-small heterodimer partner regulatory cascade modulates tissue metalloproteinase inhibitor-1 and matrix metalloprotease expression in hepatic stellate cells and promotes resolution of liver fibrosis.
Fiorucci S; Rizzo G; Antonelli E; Renga B; Mencarelli A; Riccardi L; Orlandi S; Pruzanski M; Morelli A; Pellicciari R
J Pharmacol Exp Ther; 2005 Aug; 314(2):584-95. PubMed ID: 15860571
[TBL] [Abstract][Full Text] [Related]
4. SHP-dependent and -independent induction of peroxisome proliferator-activated receptor-γ by the bile acid sensor farnesoid X receptor counter-regulates the pro-inflammatory phenotype of liver myofibroblasts.
Renga B; Mencarelli A; Migliorati M; Cipriani S; D'Amore C; Distrutti E; Fiorucci S
Inflamm Res; 2011 Jun; 60(6):577-87. PubMed ID: 21279417
[TBL] [Abstract][Full Text] [Related]
5. Antiatherosclerotic effect of farnesoid X receptor.
Mencarelli A; Renga B; Distrutti E; Fiorucci S
Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H272-81. PubMed ID: 19028791
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis.
Fiorucci S; Clerici C; Antonelli E; Orlandi S; Goodwin B; Sadeghpour BM; Sabatino G; Russo G; Castellani D; Willson TM; Pruzanski M; Pellicciari R; Morelli A
J Pharmacol Exp Ther; 2005 May; 313(2):604-12. PubMed ID: 15644430
[TBL] [Abstract][Full Text] [Related]
7. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptors and hepatic stellate cell activation.
Miyahara T; Schrum L; Rippe R; Xiong S; Yee HF; Motomura K; Anania FA; Willson TM; Tsukamoto H
J Biol Chem; 2000 Nov; 275(46):35715-22. PubMed ID: 10969082
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferated-activated receptor gamma ligand, Pioglitazone, does not prevent hepatic fibrosis in mice.
Da Silva Morais A; Abarca-Quinones J; Horsmans Y; Stärkel P; Leclercq IA
Int J Mol Med; 2007 Jan; 19(1):105-12. PubMed ID: 17143554
[TBL] [Abstract][Full Text] [Related]
10. Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro.
Galli A; Crabb DW; Ceni E; Salzano R; Mello T; Svegliati-Baroni G; Ridolfi F; Trozzi L; Surrenti C; Casini A
Gastroenterology; 2002 Jun; 122(7):1924-40. PubMed ID: 12055599
[TBL] [Abstract][Full Text] [Related]
11. PBI-4050 Reduces Stellate Cell Activation and Liver Fibrosis through Modulation of Intracellular ATP Levels and the Liver Kinase B1/AMP-Activated Protein Kinase/Mammalian Target of Rapamycin Pathway.
Grouix B; Sarra-Bournet F; Leduc M; Simard JC; Hince K; Geerts L; Blais A; Gervais L; Laverdure A; Felton A; Richard J; Ouboudinar J; Gagnon W; Leblond FA; Laurin P; Gagnon L
J Pharmacol Exp Ther; 2018 Oct; 367(1):71-81. PubMed ID: 30093459
[TBL] [Abstract][Full Text] [Related]
12. Farnesoid x receptor ligands inhibit vascular smooth muscle cell inflammation and migration.
Li YT; Swales KE; Thomas GJ; Warner TD; Bishop-Bailey D
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2606-11. PubMed ID: 18029909
[TBL] [Abstract][Full Text] [Related]
13. The farnesoid X receptor promotes adipocyte differentiation and regulates adipose cell function in vivo.
Rizzo G; Disante M; Mencarelli A; Renga B; Gioiello A; Pellicciari R; Fiorucci S
Mol Pharmacol; 2006 Oct; 70(4):1164-73. PubMed ID: 16778009
[TBL] [Abstract][Full Text] [Related]
14. Disruption of TFGβ-SMAD3 pathway by the nuclear receptor SHP mediates the antifibrotic activities of BAR704, a novel highly selective FXR ligand.
Carino A; Biagioli M; Marchianò S; Scarpelli P; Zampella A; Limongelli V; Fiorucci S
Pharmacol Res; 2018 May; 131():17-31. PubMed ID: 29530598
[TBL] [Abstract][Full Text] [Related]
15. Regulation of peroxisome proliferator-activated receptor-gamma in liver fibrosis.
Yang L; Chan CC; Kwon OS; Liu S; McGhee J; Stimpson SA; Chen LZ; Harrington WW; Symonds WT; Rockey DC
Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G902-11. PubMed ID: 16798724
[TBL] [Abstract][Full Text] [Related]
16. Antifibrotic effect of total flavonoids of Astmgali Radix on dimethylnitrosamine-induced liver cirrhosis in rats.
Cheng Y; Mai JY; Wang MF; Chen GF; Ping J
Chin J Integr Med; 2017 Jan; 23(1):48-54. PubMed ID: 27787720
[TBL] [Abstract][Full Text] [Related]
17. Effects of curcumin on peroxisome proliferator-activated receptor gamma expression and nuclear translocation/redistribution in culture-activated rat hepatic stellate cells.
Cheng Y; Ping J; Xu LM
Chin Med J (Engl); 2007 May; 120(9):794-801. PubMed ID: 17531121
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells.
Galli A; Crabb D; Price D; Ceni E; Salzano R; Surrenti C; Casini A
Hepatology; 2000 Jan; 31(1):101-8. PubMed ID: 10613734
[TBL] [Abstract][Full Text] [Related]
19. 6alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity.
Pellicciari R; Fiorucci S; Camaioni E; Clerici C; Costantino G; Maloney PR; Morelli A; Parks DJ; Willson TM
J Med Chem; 2002 Aug; 45(17):3569-72. PubMed ID: 12166927
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b.
Shipley JM; Waxman DJ
Toxicol Appl Pharmacol; 2004 Sep; 199(3):275-84. PubMed ID: 15364543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]